Stay updated on Inhaled Treprostinil in PH-COPD Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.

Latest updates to the Inhaled Treprostinil in PH-COPD Clinical Trial page
- Check6 days agoChange DetectedA new revision tag v3.5.5 was added and the previous v3.5.4 tag was removed, reflecting an update to the page's revision history.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded update dates 2026-05-27, 2026-05-22, and 2026-05; removed 2026-04-07, 2026-03-17, and 2026-03 from the Study Record Dates. These entries reflect recent edits to the page's record-keeping timestamps.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision indicator on the page was updated from v3.5.3 to v3.5.4, signaling a new build. This change does not modify the main content or functionality.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page’s displayed ClinicalTrials.gov interface revision/version number was updated, reflecting a site software release rather than a study-detail update.SummaryDifference0.0%

- Check56 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check64 days agoChange DetectedUpdated study locations: Memorial Hospital at Gulfport, MS and Petah Tikva, Israel added; a prior Petah Tikva entry removed, bringing the total number of locations to 32.SummaryDifference0.4%

Stay in the know with updates to Inhaled Treprostinil in PH-COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.